- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Attention defecit hyperactivity disorder (ADHD)
- Meeting Date: March 2020
- Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
- Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)
Methylphenidate – March 2020
Methylphenidate: Capsule containing methylphenidate hydrochloride 60 mg (modified release); Ritalin LA®
Last updated
3 July 2020